Compare LNN & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LNN | QDEL |
|---|---|---|
| Founded | 1954 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 1995 | 2022 |
| Metric | LNN | QDEL |
|---|---|---|
| Price | $115.44 | $15.06 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 4 |
| Target Price | ★ $113.00 | $28.25 |
| AVG Volume (30 Days) | 186.1K | ★ 2.1M |
| Earning Date | 04-02-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.35% | N/A |
| EPS Growth | 12.81 | ★ 45.35 |
| EPS | ★ 2.70 | N/A |
| Revenue | $676,368,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | N/A | $3.51 |
| Revenue Next Year | $4.74 | $3.86 |
| P/E Ratio | $41.96 | ★ N/A |
| Revenue Growth | ★ 11.41 | N/A |
| 52 Week Low | $97.27 | $9.92 |
| 52 Week High | $149.56 | $35.58 |
| Indicator | LNN | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 62.12 | 66.55 |
| Support Level | $105.45 | $14.45 |
| Resistance Level | $118.97 | $17.78 |
| Average True Range (ATR) | 2.79 | 0.93 |
| MACD | 0.80 | 0.47 |
| Stochastic Oscillator | 91.19 | 96.49 |
Lindsay Corp provides proprietary water management and road infrastructure products and services. It manufactures and distributes agricultural irrigation equipment through two segments: Irrigation and Infrastructure. The Irrigation segment makes center pivot, lateral move, and hose reel irrigation systems and parts. The Infrastructure segment produces barriers, crash cushions, road marking and safety equipment, and railroad signals. The majority of revenue is from the Irrigation segment. The company operates in the United States and international markets, with the majority of revenue coming from the United States.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.